Bio printing failure: causes and technical solutions

Published on June 08, 2026 | Translated from Spanish

3D bioprinting of tissues promises to revolutionize regenerative medicine, but every technical failure reveals the fragility of the process. A recent error in printing a cellular scaffold has brought the biocompatibility of hydrogels, nozzle resolution, and the internal architecture of the support to the center of the debate. We analyze the specific causes and how prior simulation can prevent structural collapse.

[Failure in 3D bioprinter showing collapsed hydrogel in cellular scaffold with detail of clogged nozzle]

Technical causes of structural collapse 🧬

The failure originated from a combination of three critical factors. First, the viscosity of the hydrogel used exceeded the limit of the pneumatic syringe, generating irregular extrusion that broke the continuity of the fibers. Second, the printer resolution (200 microns) was insufficient to replicate the microarchitecture of native tissue, causing excessively large pores that prevented cell adhesion. Third, the scaffold lacked a cross-layered design, which led to buckling during UV curing. Similar cases have been documented in laboratories at Harvard University, where the use of poorly crosslinked type I collagen caused necrosis in the center of the construct. The immediate solution involves calibrating the extrusion pressure and using hydrogels with controlled thixotropy.

3D simulation as a preventive tool 🔬

Finite element simulation allows predicting scaffold deformation before printing. Models like BioCAD software integrate parameters of elasticity, porosity, and hydrogel degradation rate. In the analyzed failure, a simulation would have detected that the fiber aspect ratio (1:8) exceeded the buckling threshold. Implementing digital twins of the tissue reduces the risk of failures by 60% according to MIT studies. The lesson is clear: in bioprinting, error is not a failure, but data to refine the model.

Since structural collapse of the hydrogel and cell death due to shear stress are two of the most critical failures in bioprinting, what technical criteria and process parameters allow predicting and avoiding these breaking points before they occur?

(PS: and if the printed organ doesn't beat, you can always add a little motor... just kidding!)